Premium
Maintenance treatment of chronic schizophrenic patients
Author(s) -
Dom R.,
Mesmaecker L. De,
Broucke M. Van Den,
Hest T. Van,
Baro F.
Publication year - 1978
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1978.tb06898.x
Subject(s) - brief psychiatric rating scale , schizophrenia (object oriented programming) , rating scale , antipsychotic , psychiatry , depression (economics) , extrapyramidal symptoms , wechsler adult intelligence scale , psychology , facilitation , medicine , psychosis , developmental psychology , cognition , neuroscience , economics , macroeconomics
The clinical effect of clopenthixol decanoate has been assessed in a 5‐month controlled study including 21 hospitalized chronic schizophrenic patients. The ratings were done with BPRS, NOSIE‐30, the two psychological tests of WAIS and Grünbaum, and the rating scale of Simpson & Angus to assess extrapyramidal side effects. Clopenthixol decanoate was found an effective and longacting antipsychotic compound with few autonomic and neurological side effects. Compared with previous maintenance treatment it also showed a positive influence on depression and facilitation of the social adaptation of the patients.